Black women with breast cancer may be more likely than white women to experience delays in beginning breast cancer treatment, as well as a longer duration of that treatment.

Chest MRI can act as a potential alternative to chest CT in follow-up of COVID-19 pneumonia when ionizing radiation exposure is a consideration.

The FDA has granted RadLogics 510(k) clearance for its AI-Powered chest x-ray pneumothorax application.

A German research team has developed an ultrasound detector that visualizes features not previously detectible by the human eye.

CEUS helps physicians diagnose some forms of liver cancer more safely and less expensively than CT and MRI, according to a report published in Hepatoma Research.

Biopharmaceutical firm Attralus has completed a $25 million Series A financing designed to further validate its AT-01 pan-amyloid radiotracer for PET/CT.

The FDA has an eye trained on healthcare AI as it establishes a major operation to help advance the state of the art across digital health.

A small but mighty research outfit based in Hungary has compiled a user-friendly database of medical technologies anchored in AI and approved by the FDA.

Cardiac MR imaging has shown potential to detect signs of myocarditis in recovered COVID-19 patients. 

In real dollars, these payers’ combined savings would have nearly reached $20 billion just in 2018, the analysis shows.